正规网赌软件十大排行在被信任方面有正规网赌软件十大排行, gold standard intelligence provider to leading 制药 brands, 制造商, 和供应商, 帮助他们做得更快, 更明智的决定.
“As a former CIA analyst, I have a very high bar for being impressed with datasets. 你们巧妙地结合在一起, 在一个统一的产品中, three qualities that are extremely difficult to achieve, 甚至个别:全面覆盖, 详尽的采购, 强调可操作性.”


发现正规网赌软件十大排行的 制药行业解决方案


使用可信数据的集体力量, 专业知识和先进技术, we provide the intelligence you need to decode the future in uncertain times.

Our solutions are designed to help you with key strategic activities.

市场 & 竞争情报
创新 & R&D



We cover the entire spectrum of the pharmaceutical value system – from suppliers, 厂家及分销渠道, all the way through to 的见解 and trends across the globe.

深入分析, 独家新闻, 和高度详细的数据库在您的指尖, we give you complete 360° insight into the 制药 Industry.

市场数据 & 的见解

  • 销售数据超过69个,000美元和126美元,全球销售的000种药物, 包括6,600 drugs analyst consensus sales and forecasts entered within 24 hours of release
  • Regulatory Milestones Tracker providing interactive search for drug expiries and reviews designations in the US, 欧盟和日本
  • 345年的报道,000 Trials (covering rare and niche diseases) – includes observational studies, 除了介入治疗和扩大治疗范围
  • 468,全球000名临床研究人员, with enrolment data on more than 500 diseases and Trial Sites
  • In-depth disease analysis and forecasts on more than 120 disease markets — spanning rare and niche indications and large, 完善的市场.
  • 疾病人群的专家分析, annualized forecasts of incident and/or prevalent cases (total or diagnosed) with multiple parameters
  • 药品定价与市场准入, 报销和市场准入策略, along with forecasting and analytical tool for up-to-date global outlook for 70 markets.


  • 独家, 强硬的, investigative reporting on pipeline drugs as well as intelligence for contract research organizations
  • Focus is on uncovering business-critical information that has not been publically divulged and providing nuanced, forward-looking analyses on market-moving healthcare topics
  • Reporting is based on talking to Key Opinion Leaders and others with first-hand expertise as well as C-level executives
  • Drug 的见解 helps subscribers conduct due diligence and assess risk on drug candidates ahead of high-impact events such as trial readouts, 审批和上市
  • Outsourcing 的见解 provides actionable information to help CROs secure new business and gain intel on their competitors
  • Content is also available via Real-Time Alerts as well as Daily and Weekly recap emails


  • 一个单一的, integrated thematic research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors
  • A theme map which monitors the disruptive impact of the top 30 to 40 themes in the sector
  • A tool to help senior executives protect their blindside, predict their industry’s future and benchmark their competitors against disruptive threats


  • 了解~ 250,000 clinical trials from Phase 0 to IV covering all diseases (including rare and niche diseases)
  • 跟踪超过50,000美元和85美元,全球销售的000种药物, 包括国家市场规模, 市场准入和监管问题, 和关键球员
  • 专家策划的评估超过1,100家公司, 包括优势, 弱点, 机会, 主要参与者的威胁分析
  • Track more than 100,000 companies globally across the pharmaceutical industry value chain


  • Focus on commercial epidemiology – deeply segmented populations by both new and emerging patient attributes, enabling precise forecasting for niche subpopulations.
  • Determine clinical development success rates by Therapy Area, Indication and Molecule Type using Likelihood of Approval and Phase Transition Success Rate tools.
  • Identify Sites and Investigators based on their clinical trials experience, 正在进行和计划中的试验, 地理和更多的东西
  • Benchmark how digital tools are being used to engage patients using Digital 市场 Intelligence, the industry’s only syndicated digital intelligence offering



  • 35岁以上,000 news alerts every year for an up-to-date view of the latest competitor landscape, 包括独家调查新闻
  • Real-time sentiment analysis of the Top-100 global “Influencers” in the 制药 Industry
  • In-depth coverage of more than 50 international conferences in the US, Europe and Asia.


  • 数据库超过85,000 M&A, strategic alliances and financial transactions for a comprehensive view of investments opportunities
  • M的实时监控&一个活动, 战略联盟, 融资及拨款, 超过7,每年确认和分析的新交易多达000笔


  • Unlimited “Ask an Analyst” functionality with 24-48 hour response time to accelerate decision making



Decode the future by discovering our 制药行业解决方案. Request a free no-obligation run-through of our unique and powerful tools.



We produce hundreds of quantitative and qualitative reports annually. 从战略报告, 行业预测报告, 行业报告, 小组报告, 洞察报告, 趋势跟踪器, 和国家概况.



Our consulting services provide you with contextualized, real time market 的见解. Our consultants are highly experienced in helping clients identify new opportunities, 最小化风险, gain competitive advantage and improve profitability.

友情链接: 1 2 3 4 5 6 7 8 9 10